Search

Your search keyword '"Tetrud, J."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Tetrud, J." Remove constraint Author: "Tetrud, J." Database MEDLINE Remove constraint Database: MEDLINE
37 results on '"Tetrud, J."'

Search Results

1. Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease.

2. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

3. Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.

4. Novel features in a patient homozygous for the L347P mutation in the PINK1 gene.

5. Treatment challenges in early stage Parkinson's disease.

6. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology.

7. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease.

8. An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease.

9. A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.

10. Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.

11. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.

12. Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental method.

13. Autopsy-proven progressive supranuclear palsy in two siblings.

14. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.

15. Parkinsonism caused by petroleum waste ingestion.

16. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.

17. Oral levodopa/carbidopa solution versus tablets in Parkinson's patients with severe fluctuations: a pilot study.

18. Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism.

19. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

20. Lack of major olfactory dysfunction in MPTP-induced parkinsonism.

21. Protective and preventive therapeutic strategies: monoamine oxidase inhibitors.

22. Tremor in MPTP-induced parkinsonism.

23. Preclinical detection of motor and nonmotor manifestations.

24. An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients.

25. Preclinical Parkinson's disease: detection of motor and nonmotor manifestations.

28. The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease.

29. Cognitive change following MPTP exposure.

30. Pseudo-ileovesical fistula in Crohn disease.

31. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease.

32. R-(-)-deprenyl as a possible protective agent in Parkinson's disease.

33. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.

34. MPTP-induced parkinsonism as a model for Parkinson's disease.

35. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

36. Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Catalog

Books, media, physical & digital resources